Severity 4 of 5
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Severity 4 (Severe) recalls have a real, documented risk of significant injury, hospitalization, or property damage even if no deaths have been reported. The agency classification is FDA Class II with hospitalization reports, USDA Class I, or a structural vehicle defect. These need attention quickly — not five-alarm urgency but not something to put off. Examples include allergen mislabeling on common allergens for products eaten by children, drug potency out of specification by a margin that could cause measurable harm, and vehicle defects affecting braking or steering.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Aidapak Services is recalling Perphenazine 16 mg tablets because they may have been mislabeled as other prescription drugs.
Cubist Pharmaceuticals is recalling 179,870 vials of Cubicin (daptomycin for injection) due to the presence of glass particulates.
Aidapak Services, LLC is recalling 5 mg rosuvastatin calcium tablets because they may have been mislabeled as ibuprofen or ascorbic acid.
Aidapak Services, LLC is recalling Thiamine HCL 100 mg tablets because they may have been mislabeled as other drugs, including simvastatin and buprenorphine.
Aidapak Services, LLC is recalling Bismuth Subsalicylate chewable tablets that may have been mislabeled as Irbesartan. The error could lead to patients taking the wrong medication.
Aidapak Services is recalling chlorpromazine HCl tablets that may be mislabeled as acamprosate calcium. The error could lead to patients receiving the wrong medication.
Aidapak Services is recalling Minoxidil 2.5 mg tablets because they may have been mislabeled as methylprednisolone 4 mg.
Aidapak Services, LLC is recalling glyBURIDE tablets that may have been mislabeled as other prescription drugs. The error poses a risk of patients receiving incorrect medication.
Aidapak Services is recalling dexamethasone tablets that may have been mislabeled as venlafaxine capsules.
Aidapak Services is recalling 16 mg Perphenazine tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling 500 mg Ascorbic Acid tablets because they may have been mislabeled as Venlafaxine HCL 100 mg.
Codman & Shurtleff, Inc. is recalling 7,983 units of the TRUFILL n-BCA Liquid Embolic System due to incorrect instructions for use.
Aidapak Services, LLC is recalling methylprednisolone tablets that may have been mislabeled as levothyroxine, nabumetone, or cholecalciferol.
Aidapak Services, LLC is recalling 10 mg Piroxicam capsules because they may have been mislabeled as Hyoscyamine Sulfate. The error could lead to patients receiving the wrong medication.
Aidapak Services is recalling Tri-Buffered Aspirin tablets because they may have been mislabeled as a different medication. The error involves a potential mix-up with Isometheptene Mucate/Dichlorphenazone/APAP capsules.
Aidapak Services, LLC is recalling Phenobarbital tablets that may have been mislabeled as Efavirenz capsules. The error involves a label mixup during repacking.
Aidapak Services is recalling Niacin TR capsules because they may have been mislabeled as other drugs like Perphenazine or Melatonin.
Aidapak Services, LLC is recalling Minocycline HCL capsules because they may have been mislabeled as Minoxidil tablets. The error could lead to patients receiving the wrong medication.
Hospira is recalling 126,425 vials of Propofol Injectable Emulsion due to a glass defect that could release particulate matter into the solution.
Aidapak Services is recalling Digoxin tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling 80 mg Atorvastatin Calcium tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Acetaminophen/Butalbital/Caffeine tablets that may have been mislabeled as Aspirin. The error could cause patients to take the wrong medication.
Aidapak Services is recalling Phenobarbital tablets that may be mislabeled as Pregabalin capsules. The error poses a risk of patients receiving the wrong medication.
Giant Eagle is recalling Candy Place Chocolate Santas because the peanut allergen is not declared on the primary label and the caramel variety ingredient statement is missing.
Aidapak Services, LLC is recalling Levothyroxine Sodium 88 mcg tablets because they may have been mislabeled as other prescription drugs.